TipRanks
Advertisement
Advertisement
Encoded Therapeutics Secures $275 Million to Advance Gene Therapy Pipeline and Manufacturing
PremiumPrivate CompaniesEncoded Therapeutics Secures $275 Million to Advance Gene Therapy Pipeline and Manufacturing
30d ago
Encoded Therapeutics Secures $275 Million Financing to Advance Gene Therapy Pipeline
Premium
Private Companies
Encoded Therapeutics Secures $275 Million Financing to Advance Gene Therapy Pipeline
30d ago
Encoded Therapeutics Anticipates New Phase 1/2 ETX101 Data at EEC 2026
Premium
Private Companies
Encoded Therapeutics Anticipates New Phase 1/2 ETX101 Data at EEC 2026
1M ago
Patient-Centric Focus Highlights Encoded Therapeutics’ Engagement in Dravet Syndrome
PremiumPrivate CompaniesPatient-Centric Focus Highlights Encoded Therapeutics’ Engagement in Dravet Syndrome
4M ago
Encoded Therapeutics Builds Momentum In Dravet Gene Therapy Ahead Of Key ETX101 Data
Premium
Private Companies
Encoded Therapeutics Builds Momentum In Dravet Gene Therapy Ahead Of Key ETX101 Data
4M ago
Encoded Therapeutics Highlights Progress of ETX101 Clinical Program in Dravet Syndrome
Premium
Private Companies
Encoded Therapeutics Highlights Progress of ETX101 Clinical Program in Dravet Syndrome
4M ago
Encoded Therapeutics Emphasizes Focus on Dravet Syndrome and Patient Community Engagement
PremiumPrivate CompaniesEncoded Therapeutics Emphasizes Focus on Dravet Syndrome and Patient Community Engagement
4M ago
Encoded Therapeutics Highlights Strategic Focus on Dravet Syndrome and Patient Community Engagement
Premium
Private Companies
Encoded Therapeutics Highlights Strategic Focus on Dravet Syndrome and Patient Community Engagement
4M ago
Encoded Therapeutics Advances ETX101 Toward Pivotal Stage and Expands Gene Therapy Pipeline
Premium
Private Companies
Encoded Therapeutics Advances ETX101 Toward Pivotal Stage and Expands Gene Therapy Pipeline
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―